Meta Antitrust Trial Begins as Workday Surges on Fresh Takeover Speculation

The Quick Take

• Meta Platforms begins landmark FTC antitrust trial challenging its Instagram and WhatsApp acquisitions
• Workday shares surged on renewed takeover speculation with strategic and financial acquirers named
• Meta trial outcome could reshape Big Tech M&A standards and force retroactive divestitures
• Workday's HCM platform strategic value makes it a perennial M&A target at the right price
• Dual catalysts highlight market sensitivity to both regulatory and deal-making news flows

The FTC's antitrust trial against Meta Platforms represents the most consequential regulatory proceeding in US tech since the Microsoft antitrust case of the 1990s. The government's theory — that Meta's 2012 Instagram and 2014 WhatsApp acquisitions were anticompetitive acts that neutralized nascent social media threats — if upheld, could force divestiture of those assets and fundamentally alter how the FTC evaluates future Big Tech M&A. For Meta investors, the trial creates a binary overhang: a government win requiring structural remedies affecting two of Meta's most valuable assets; a government loss removing a major regulatory tail risk.

The Workday takeover speculation represents pure M&A optionality. Workday's enterprise human capital management and financial management software suite serves a deeply embedded customer base under long-term contracts, creating predictable subscription revenue that strategic acquirers — whether technology giants, enterprise software consolidators, or private equity — assign premium multiples to. At any given moment, multiple potential acquirers are plausibly evaluating Workday's strategic fit: Salesforce for CRM integration, Oracle for direct HCM competition, or PE firms for a take-private at higher leverage.

The confluence of these two stories on a single trading day illustrates the divergent forces shaping technology equity valuations in mid-2026: regulatory risk compressing multiples at the largest platforms while deal-making premiums inflate mid-large cap software names. For portfolio managers, the pair trade opportunity is evident — long Workday optionality against short regulatory overhang on Meta — though execution requires careful position sizing given the non-linear payoff profiles of both catalysts. The Meta trial could extend over weeks of testimony, while Workday deal speculation may resolve quickly if a formal offer fails to emerge.

Synthesized from 1 source.